The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Standard BioTools Inc shares valued at $123,098 were purchased by Black Jeffrey G. on Nov 12 ’24. At $2.12 per share, Black Jeffrey G. acquired 57,971 shares.
Also, Taich Adam purchased 45,851 shares, netting a total of over 91,725 in proceeds.
Before that, Casdin Partners Master Fund, L had added 250,000 shares to its account. In a trade valued at $546,750, the Director bought Standard BioTools Inc shares for $2.19 each. Upon closing the transaction, the insider’s holdings increased to 250,000 shares, worth approximately $94.55 million.
As published in their initiating research note from TD Cowen on April 16, 2024, Standard BioTools Inc [LAB] has been a Buy and the price target has been revised to $3.50. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of July 12, 2023, KeyBanc Capital Markets has initiated its “an Overweight” rating for LAB.
Analyzing LAB Stock Performance
During the last five days, there has been a drop of approximately -4.37%. Shares of the company reached a 52-week high of $1.8000 on 01/02/25 and a 52-week low of $1.7100 on 01/02/25. A 50-day SMA is recorded $1.8655, while a 200-day SMA reached $2.1078. Nevertheless, trading volume fell to 1.3 million shares from 0.84 million shares the previous day.
Support And Resistance Levels for Standard BioTools Inc (LAB)
According to the 24-hour chart, there is a support level at 1.7067, which, if violated, would cause prices to drop to 1.6633. In the upper region, resistance lies at 1.7967. The next price resistance is at 1.8433. RSI (Relative Strength Index) is 43.05 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1608, which suggests the price will decrease in the coming days. Percent R is at 92.59%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
